Found 155 matching trials
Use of Thalidomide, Lenalidomide, Carfilzomib, Bortezomib and Vorinostat in the Initial Treatment of Newly Diagnosed Multiple Myeloma Patients PHASE3 The purpose of this study is to compare a standard chemotherapy regimen of ...
Show More Location
112 sites UK wide
Treatments Being Tested
Induction (intensive pathway) - cyclophosphamide, lenalidomide, & dexamethasone (CRD) regimen Induction (intensive pathway) - cyclophosphamide, thalidomide, & dexamethasone (CTD) regimen Induction (intensive pathway) - carfilzomib, cyclophosphamide, lenalidomide, & dexamethasone (CCRD) regimen Induction (non-intensive pathway) - cyclophosphamide, lenalidomide, & dexamethasone attenuated (CRDa) regimen Induction (non-intensive pathway) - cyclophosphamide, thalidomide, & dexamethasone attenuated (CTDa) regimen Consolidation (intensive & non-intensive pathways) - bortezomib, cyclophosphamide, & dexamethasone (VCD) regimen Maintenance (intensive & non-intensive pathways) - lenalidomide maintenance Maintenance (intensive & non-intensive pathways - protocol v5.0 only) - lenalidomide plus vorinostat maintenance High dose melphalan therapy and autologous stem cell transplant (intensive pathway only) Learn More & Join Trial
Belantamab Mafodotin or Daratumumab With Bortezomib, Lenalidomide and Dexamethasone for Newly Diagnosed Multiple Myeloma PHASE3 Eligible participants with newly diagnosed myeloma who are not considered e...
Show More Location
Gundersen Lutheran
Learn More & Join Trial
A Study Comparing JNJ-68284528, a CAR-T Therapy Directed Against B-cell Maturation Antigen (BCMA), Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) or Daratumumab, Pomalidomide and Dexamethasone (DPd) in Participants With Relapsed and Lenalidomide-Refractory Multiple Myeloma PHASE3 The purpose of this study is to compare the efficacy of ciltacabtagene auto...
Show More Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Learn More & Join Trial
CM336 Plus Isa-VR in Newly Diagnosed Primary Plasma Cell Leukemia PHASE2 The goal of this clinical trial is to learn whether CM336, a BCMA/CD3 bispe...
Show More Location
Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences
Learn More & Join Trial
Bortezomib, Thalidomide, and Dexamethasone After Melphalan and Stem Cell Transplant in Treating Patients With Stage I-III Multiple Myeloma PHASE2 RATIONALE: Bortezomib and thalidomide may stop the growth of multiple myelo...
Show More Location
City of Hope Medical Center
Learn More & Join Trial
Selinexor With Alternating Bortezomib or Lenalidomide Plus Dexamethasone in TIE Newly Diagnosed MM Patients PHASE2 An unrandomized phase 2 study of selinexor in combination with lenalidomide...
Show More Status
Active Not Recruiting
Location
Aalborg University Hospital
Learn More & Join Trial
Bortezomib and Filgrastim to Promote Stem Cell Mobilization in Patients With Non-Hodgkin Lymphoma or Multiple Myeloma NA This clinical trial studies peripheral blood hemapoietic stem cell mobiliza...
Show More Location
Barbara Ann Karmanos Cancer Institute
Learn More & Join Trial
Determination 2 - Isatuximab, Iberdomide, Bortezomib and Dexamethasone Induction, Followed by Risk- and Response-Adapted Consolidation and Maintenance Therapy, in Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma PHASE3 The purpose of the study is to determine the best treatment approach based ...
Show More Location
Beth Israel Deaconess Medical Center (BIDMC)
Learn More & Join Trial
Phase 3 Study With Carfilzomib and Dexamethasone Versus Bortezomib and Dexamethasone for Relapsed Multiple Myeloma Patients PHASE3 The primary objective of this study was to compare progression-free surviva...
Show More Location
Providence St. Joseph Medical Center
Learn More & Join Trial
Chemotherapy, Stem Cell Transplantation and Donor and Patient Vaccination for Treatment of Multiple Myeloma PHASE2 Background:
The mainstay of therapy for newly diagnosed multiple myeloma p...
Show More Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Learn More & Join Trial